
Harrow Health Inc
NASDAQ:HROW

Intrinsic Value
The intrinsic value of one
HROW
stock under the Base Case scenario is
90.08
USD.
Compared to the current market price of 26.43 USD,
Harrow Health Inc
is
Undervalued by 71%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Harrow Health Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Harrow Health Inc
Balance Sheet Decomposition
Harrow Health Inc
Current Assets | 169.5m |
Cash & Short-Term Investments | 66.7m |
Receivables | 77.3m |
Other Current Assets | 25.5m |
Non-Current Assets | 194.6m |
PP&E | 11.9m |
Intangibles | 182.7m |
Free Cash Flow Analysis
Harrow Health Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Harrow Health Inc
Revenue
|
212.9m
USD
|
Cost of Revenue
|
-54.2m
USD
|
Gross Profit
|
158.6m
USD
|
Operating Expenses
|
-154.1m
USD
|
Operating Income
|
4.5m
USD
|
Other Expenses
|
-26.2m
USD
|
Net Income
|
-21.7m
USD
|
HROW Profitability Score
Profitability Due Diligence
Harrow Health Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Score
Harrow Health Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
HROW Solvency Score
Solvency Due Diligence
Harrow Health Inc's solvency score is 32/100. The higher the solvency score, the more solvent the company is.

Score
Harrow Health Inc's solvency score is 32/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
HROW Price Targets Summary
Harrow Health Inc
According to Wall Street analysts, the average 1-year price target for
HROW
is 58.59 USD
with a low forecast of 52.72 USD and a high forecast of 68.25 USD.
Dividends
Current shareholder yield for HROW is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
HROW
stock under the Base Case scenario is
90.08
USD.
Compared to the current market price of 26.43 USD,
Harrow Health Inc
is
Undervalued by 71%.